{"id":"https://openalex.org/W2129743526","doi":"https://doi.org/10.1002/pds.3872","title":"More realistic power estimation for new user, active comparator studies: an empirical example","display_name":"More realistic power estimation for new user, active comparator studies: an empirical example","publication_year":2015,"publication_date":"2015-09-11","ids":{"openalex":"https://openalex.org/W2129743526","doi":"https://doi.org/10.1002/pds.3872","mag":"2129743526","pmid":"https://pubmed.ncbi.nlm.nih.gov/26360635","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4788577"},"language":"en","primary_location":{"id":"doi:10.1002/pds.3872","doi":"https://doi.org/10.1002/pds.3872","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3872","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4788577","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030404824","display_name":"Mugdha Gokhale","orcid":"https://orcid.org/0000-0003-0223-1016","observed_orcids":["https://orcid.org/0000-0003-0223-1016"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mugdha Gokhale","raw_affiliation_strings":["Department of Epidemiology; University of North Carolina at Chapel Hill; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology; University of North Carolina at Chapel Hill; USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876","https://orcid.org/0000-0001-6894-4110"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John B. Buse","raw_affiliation_strings":["Department of Medicine; University of North Carolina School of Medicine; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine; University of North Carolina School of Medicine; USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036291591","display_name":"Virginia Pate","orcid":"https://orcid.org/0000-0002-2141-8882","observed_orcids":["https://orcid.org/0000-0002-2141-8882"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia Pate","raw_affiliation_strings":["Department of Epidemiology; University of North Carolina at Chapel Hill; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology; University of North Carolina at Chapel Hill; USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Alison Marquis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Alison Marquis","raw_affiliation_strings":["Collaborative Studies Coordinating Center, Department of Biostatistics; University of North Carolina at Chapel Hill; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collaborative Studies Coordinating Center, Department of Biostatistics; University of North Carolina at Chapel Hill; USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043069598","display_name":"Til St\u00fcrmer\u200e","orcid":"https://orcid.org/0000-0002-9204-7177","observed_orcids":["https://orcid.org/0000-0002-9204-7177"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Til St\u00fcrmer","raw_affiliation_strings":["Department of Epidemiology; University of North Carolina at Chapel Hill; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology; University of North Carolina at Chapel Hill; USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030404824"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.08802997,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"25","issue":"4","first_page":"462","last_page":"466"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14374","display_name":"Statistical Methods in Epidemiology","score":0.486299991607666,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14374","display_name":"Statistical Methods in Epidemiology","score":0.486299991607666,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.4717000126838684,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statistical-power-estimation","display_name":"statistical power estimation","score":0.7170000076293945},{"id":"https://openalex.org/keywords/sample-size","display_name":"sample size","score":0.5210000276565552},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.47600001096725464},{"id":"https://openalex.org/keywords/pancreatic-cancer-incidence","display_name":"pancreatic cancer incidence","score":0.6930000185966492},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":1.0},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8447139263153076},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.676358163356781},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6174885034561157},{"id":"https://openalex.org/C137668524","wikidata":"https://www.wikidata.org/wiki/Q189813","display_name":"Censoring (clinical trials)","level":2,"score":0.5982092618942261},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.45692017674446106},{"id":"https://openalex.org/C185429906","wikidata":"https://www.wikidata.org/wiki/Q1130160","display_name":"Estimator","level":2,"score":0.4432944357395172},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.4379042387008667},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.41966676712036133},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4151979982852936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3094961643218994},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23008617758750916},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.1111198365688324},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0915052592754364},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015340","descriptor_name":"Epidemiologic Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015982","descriptor_name":"Bias","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017891","descriptor_name":"Pharmacoepidemiology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018401","descriptor_name":"Sample Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/pds.3872","doi":"https://doi.org/10.1002/pds.3872","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3872","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:26360635","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26360635","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:4788577","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4788577","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pharmacoepidemiol Drug Saf","raw_type":"Text"},{"id":"pmh:cdr.lib.unc.edu:4b29bb78z","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.17615/78hg-fy90","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacoepidemiology and Drug Safety, 25(4)","raw_type":"Article"},{"id":"doi:10.17615/78hg-fy90","doi":"https://doi.org/10.17615/78hg-fy90","is_oa":true,"landing_page_url":"https://doi.org/10.17615/78hg-fy90","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4788577","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4788577","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pharmacoepidemiol Drug Saf","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G3969538665","display_name":"North Carolina Translational & Clinical Sciences Institute (NC TraCS)","funder_award_id":"UL1TR001111","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5711986348","display_name":"A retrospective cohort study of the safety of testosterone therapy in older men","funder_award_id":"R01AG042845","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G6602935441","display_name":"UNC Clinical and Translational Science Award","funder_award_id":"UL1RR025747","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G6628848920","display_name":"North Carolina Translational and Clinical Science Institute (NC TraCS)","funder_award_id":"UL1TR002489","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7321790531","display_name":null,"funder_award_id":"1 ULI RR025747","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G7441241992","display_name":"PROMIS Validation in Prospective Population-based Prostate Cancer Research Study","funder_award_id":"R01CA174453","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8013340669","display_name":"Propensity Scores and Preventive Drug Use in the Elderly","funder_award_id":"R01AG023178","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320308927","display_name":"Patient-Centered Outcomes Research Institute","ror":"https://ror.org/014q65q44"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337683","display_name":"School of Medicine, University of North Carolina at Chapel Hill","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W16275066","https://openalex.org/W1576424227","https://openalex.org/W1996666156","https://openalex.org/W2073225472","https://openalex.org/W2090132603","https://openalex.org/W2112981414","https://openalex.org/W2120774442","https://openalex.org/W2125436438","https://openalex.org/W2144113585","https://openalex.org/W2153983975","https://openalex.org/W2262573287"],"related_works":["https://openalex.org/W4300217161","https://openalex.org/W1849521086","https://openalex.org/W3004528805","https://openalex.org/W3043216414","https://openalex.org/W4404685489","https://openalex.org/W4408387760","https://openalex.org/W2589233098","https://openalex.org/W6944252855","https://openalex.org/W3113630075","https://openalex.org/W7096335518"],"abstract_inverted_index":{"PURPOSE:":[0],"Pharmacoepidemiologic":[1],"studies":[2],"are":[3],"often":[4],"expected":[5],"to":[6,10,101,128,241],"be":[7,200],"sufficiently":[8],"powered":[9],"study":[11,24,34],"rare":[12],"outcomes,":[13],"but":[14],"there":[15],"is":[16],"sequential":[17],"loss":[18],"of":[19,23,58,79,112,145,209,222,230],"power":[20,125,178,185,231],"with":[21,53,122,161,233],"implementation":[22],"design":[25],"options":[26],"minimizing":[27,204],"bias.":[28],"We":[29,49],"illustrate":[30],"this":[31],"using":[32],"a":[33,76,152,170],"comparing":[35],"pancreatic":[36],"cancer":[37,163],"incidence":[38],"after":[39,117,150,158,168,187],"initiating":[40],"dipeptidyl-peptidase-4":[41],"inhibitors":[42],"(DPP-4i)":[43],"versus":[44],"thiazolidinediones":[45],"or":[46,60],"sulfonylureas.":[47],"METHODS:":[48],"identified":[50],"Medicare":[51],"beneficiaries":[52],"at":[54],"least":[55],"one":[56,198],"claim":[57],"DPP-4i":[59,137],"comparators":[61],"during":[62,98,141],"2007-2009":[63],"and":[64,92,135,138,164,173,211],"then":[65],"applied":[66],"the":[67,110,123,184,188,234],"following":[68],"steps:":[69],"(i)":[70],"exclude":[71,83,87],"prevalent":[72,84,162],"users,":[73],"(ii)":[74],"require":[75],"second":[77,153,171],"prescription":[78,172],"same":[80],"drug,":[81],"(iii)":[82],"cancers,":[85],"(iv)":[86],"patients":[88,160],"age":[89],"<66":[90],"years":[91],"(v)":[93],"censor":[94],"for":[95],"treatment":[96],"changes":[97],"follow-up.":[99],"Power":[100],"detect":[102],"hazard":[103],"ratios":[104],"(effect":[105],"measure":[106],"strongly":[107],"driven":[108],"by":[109],"number":[111,144,208],"events)":[113],"\u2265":[114],"2.0":[115],"estimated":[116,126],"step":[118,129,190],"5":[119],"was":[120,180],"compared":[121,232],"na\u00efve":[124,177],"prior":[127],"1.":[130],"RESULTS:":[131],"There":[132],"were":[133],"19,388":[134],"28,846":[136],"thiazolidinedione":[139],"initiators":[140,147],"2007-2009.":[142],"The":[143,176],"drug":[146],"dropped":[148,156,166],"most":[149,157,167],"requiring":[151,169],"prescription,":[154],"outcomes":[155,210],"excluding":[159],"person-time":[165],"as-treated":[174],"censoring.":[175],"(>99%)":[179],"considerably":[181],"higher":[182],"than":[183],"obtained":[186],"final":[189],"(~75%).":[191],"CONCLUSIONS:":[192],"In":[193],"designing":[194],"new-user":[195],"active-comparator":[196],"studies,":[197],"should":[199],"mindful":[201],"how":[202],"steps":[203,239],"bias":[205],"affect":[206],"sample-size,":[207],"person-time.":[212],"While":[213],"actual":[214],"numbers":[215],"will":[216,227],"depend":[217],"on":[218],"specific":[219],"settings,":[220],"application":[221],"generic":[223],"losses":[224],"in":[225],"percentages":[226],"improve":[228],"estimates":[229],"naive":[235],"approach":[236],"mostly":[237],"ignoring":[238],"taken":[240],"increase":[242],"validity.":[243]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}